Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities

Aberrant DNA methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Recent advances in genome-wide methylation methods have provided the means to identify differentially methylated genes, methylation signatures, and potential biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Micevic, Goran, Theodosakis, Nicholas, Bosenberg, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381063/
https://www.ncbi.nlm.nih.gov/pubmed/28396701
http://dx.doi.org/10.1186/s13148-017-0332-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381063/
https://www.ncbi.nlm.nih.gov/pubmed/28396701
http://dx.doi.org/10.1186/s13148-017-0332-8

Ejemplares similares